Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaozheng pill vs Guizhi Fuling Capsule for uterine leiomyoma
ChiCTR2100051236Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4 trial of Xiaozheng Pill in Fibromyoma (LM) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Volume of uterine fibroids. Started Sep 2021; status: recruiting.
02
Drugs
Xiaozheng Pill
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR2100051236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051236.